Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom (Q38021421)

27 August 2017

Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom (English)

1 reference

27 August 2017

1 reference

diabetic macular edema

1 reference

Tunde Peto

1

0 references

author name string

Christine Tadros

series ordinal

2

1 reference

27 August 2017

1 August 2012

1 reference

27 August 2017

Current diabetes report

1 reference

27 August 2017

12

1 reference

27 August 2017

338-345

1 reference

27 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-012-0285-4

27 August 2017

0 references

cites work

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Screening and prevention of diabetic blindness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

The English national screening programme for sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Trends in the incidence of visual impairment certification secondary to diabetic retinopathy in the Leeds metropolitan area, 2005-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Are individuals with diabetes seeing better?: a long-term epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Diabetic retinopathy and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Screening compliance and visual outcome in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Cost effectiveness analysis of screening for sight threatening diabetic eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Biennial eye screening in patients with diabetes without retinopathy: 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Diabetic retinopathy screening: a systematic review of the economic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Diabetic retinopathy in a multi-ethnic cohort in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

A potential pathway for managing diabetic patients with arterial emboli detected by retinal screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0285-4

Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review

21 January 2018

1 reference

12 December 2020

Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

1 reference

12 December 2020

Assessment of automated disease detection in diabetic retinopathy screening using two-field photography

1 reference

12 December 2020

The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial

1 reference

12 December 2020

Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy

1 reference

12 December 2020

1 reference

12 December 2020

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

1 reference

12 December 2020

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

10.1007/S11892-012-0285-4

Identifiers

DOI

1 reference

PubMed ID

22729994

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

22729994